Today, Austin discusses the potential for pharmaceutical giant Walgreen (NASDAQ:WBA). The company's dividend and wide-ranging store basis give it a promising base network, but it still faces an uphill battle. Competitor CVS uses its own PBM, and the Express Scripts fallout continues to plague Walgreen. The recent Boots purchase will make it even harder for the company to shore up domestic issues, and it will struggle to grow unless a company like Rite Aid goes under and surrenders market share. Austin remains bearish on Walgreen and rates it as a definite sell.

If you're interested in some of these dividends on your quest for high-yielding stocks, The Motley Fool has compiled a special free report outlining our nine top dependable dividend-paying stocks. It's called  "Secure Your Future With 9 Rock-Solid Dividend Stocks." You can access your complimentary copy today at no cost! Just click here to discover the winners we've picked.